Personalis Inc Receivables Turnover Ratio (PSNL), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Personalis Inc   (NASDAQ: PSNL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Personalis Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Personalis Inc 's ability to collect accounts receivable sequentially worsen to 4.75, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Personalis Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 77 days, from 76 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 416 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1787 to 2743.

What is Receivable Turnover Ratio?
What is Personalis Inc Selling?


What is Receivable Turnover Ratio?





PSNL Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 51.75 % 18.67 % 99.05 % 6.69 % -22.98 %
Y / Y Revenue Change 29.96 % -24.91 % 3.24 % -43.62 % -23.81 %
Receivable Turnover Ratio (TTM) 4.75 4.82 5.41 6.36 7.55
PSNL's Total Ranking # 2743 # 1787 # 2459 # 1578 # 2296
Accounts Receivable average collection period days 77 76 67 57 48
Seq. Receivable Change 15.97 % -19.63 % 12.71 % 44.45 % -9.3 %
Seq. Revenue Change 44.5 % -10.8 % 19.66 % -15.74 % -16.51 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 26
Healthcare Sector # 417
Overall Market # 2743

Receivable Turnover Ratio Statistics
High Average Low
0.41 0.26 0.12
(Sep 30 2024)   (Mar 31 2020)






Financial Statements
Personalis Inc 's Accounts Receivable $ 15 Millions Visit PSNL's Balance sheet
Personalis Inc 's Sales TTM $ 70 Millions Visit PSNL's Income Statement
Sources of PSNL's Revenues Visit PSNL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PSNL's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PSNL's Growth Rates PSNL's Roa PSNL's Inventory Turnover Ratio PSNL's Dividend Comparisons
PSNL's Profitability Ratios PSNL's Roi PSNL's Asset Turnover Ratio PSNL's Dividend Growth
PSNL's Valuation Ratios PSNL's Roe PSNL's Financial Strength Ratios PSNL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Radnet Inc   10.53 $ 2,268.932  Millions$ 215.450  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Irhythm Holdings Inc   10.42 $ 825.702  Millions$ 79.250  Millions
Integrated Biopharma Inc  10.38 $ 42.568  Millions$ 4.101  Millions
Viemed Healthcare Inc   10.36 $ 301.606  Millions$ 29.102  Millions
Lensar Inc   10.33 $ 60.264  Millions$ 5.836  Millions
Immucell Corporation  10.30 $ 29.777  Millions$ 2.891  Millions
Addus Homecare Corp  10.25 $ 1,475.610  Millions$ 143.923  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Biodesix Inc   10.21 $ 102.939  Millions$ 10.081  Millions
Kestra Medical Technologies Ltd   10.00 $ 105.939  Millions$ 10.590  Millions

Date modified: 2026-09-26T07:36:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.